Lean adults with HIV on long-term antiretroviral therapy had a higher median carotid-femoral augmentation index (21.1% vs. 6.0%) and increased immune activation compared to HIV-negative persons.
Cross-Sectional (n=74)
No
Does HIV infection and immune activation increase arterial stiffness in lean adults on long-term antiretroviral therapy?
Lean adults with HIV on long-term antiretroviral therapy exhibit increased immune activation and arterial stiffness compared to HIV-negative controls, highlighting cardiovascular risk even in non-obese patients.
Absolute Event Rate: 21.1% vs 6%
p-value: p=0.04
Background: Greater T-cell activation was associated with reduced vascular compliance amongst persons living with HIV (PLWH) especially among overweight and obese individuals. There is a paucity of data regarding immune activation and arterial stiffness amongst PLWH in sub-Saharan Africa (SSA). Objective: To determine the association between immune activation and arterial stiffness in lean PLWH in SSA. Method: Forty-eight human immunodeficiency virus positive (HIV+) adults on antiretroviral therapy (ART) >5 years and 26 HIV-negative adults, all with BMI < 25 kg/m 2 and no history of CVD, were enrolled. The relationship of vascular compliance with circulating CD4+ and CD8+ naïve, memory, activated and senescent T cells, and serum 8-isoprostane was assessed by HIV status. Results: Increased immune activation was observed in the CD4+ and CD8+ T cells of PLWH, 16.7% vs. 8.9% and 22.0% vs. 12.4% respectively; p < 0.001 (both). Furthermore, a higher proportion of senescent CD4+ T cells were associated with a lower carotid-femoral pulse wave velocity (cfPWV; p = 0.01), whilst a higher proportion of activated CD8+ T cells were associated with a lower carotid-radial pulse wave velocity (crPWV; p = 0.04), after adjustment for BMI and age. However, PLWH also had a higher median carotid-femoral augmentation index (cfAiX) (21.1% vs. 6.0%; p < 0.05) in comparison to their HIV controls. Conclusion: Our population of lean PLWH had increased immune activation and higher cfAiX, a marker of arterial stiffness, compared to HIV-negative persons. The negative association between immune activation and arterial stiffness as measured by crPWV in PLHW on long-term treatment needs further elucidation.
Kaluba et al. (Fri,) conducted a cross-sectional in HIV (n=74). HIV infection (on long-term ART) vs. HIV-negative was evaluated on Carotid-femoral augmentation index (cfAiX) (p=0.04). Lean adults with HIV on long-term antiretroviral therapy had a higher median carotid-femoral augmentation index (21.1% vs. 6.0%) and increased immune activation compared to HIV-negative persons.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: